Candriam Equities L Biotech.V2 USD Acc/ LU2026682919 /
NAV2024-07-25 | Chg.+20.8099 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
2,051.3999USD | +1.02% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | - | - | - | - | - | - | - | - | 0.79 | -2.58 | 9.54 | 3.06 | - |
2021 | 1.89 | -2.53 | -4.20 | 2.79 | -2.19 | 6.44 | -1.39 | 3.98 | -4.17 | 0.23 | -4.31 | 2.49 | -1.66% |
2022 | -10.51 | -1.49 | 6.13 | -7.16 | -3.90 | 3.59 | 4.79 | 1.62 | -1.83 | 6.58 | 6.26 | -2.79 | -0.47% |
2023 | 3.00 | -5.59 | 0.33 | 2.35 | -0.85 | 1.51 | -0.49 | -0.14 | -4.41 | -6.03 | 6.25 | 13.72 | +8.38% |
2024 | 1.58 | 1.43 | 0.05 | -6.16 | 3.91 | 5.73 | 6.98 | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 16.03% | 16.20% | 16.74% | 20.16% | -% |
Sharpe ratio | 1.37 | 1.29 | 1.17 | 0.14 | - |
Best month | +13.72% | +6.98% | +13.72% | +13.72% | - |
Worst month | -6.16% | -6.16% | -6.16% | -10.51% | - |
Maximum loss | -10.91% | -10.91% | -12.28% | -28.30% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
YTD | +13.68% | ||
---|---|---|---|
6 Months | +11.61% | ||
1 Year | +23.27% | ||
3 Years | +20.87% | ||
5 Years | - | ||
10 Years | - | ||
Since start | +36.76% | ||
Year | |||
2023 | +8.38% | ||
2022 | -0.47% | ||
2021 | -1.66% |